Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease.
Group B Streptococcus
Molecular mimicry
Post-infection arthritis
Streptococcal
Journal
Current rheumatology reports
ISSN: 1534-6307
Titre abrégé: Curr Rheumatol Rep
Pays: United States
ID NLM: 100888970
Informations de publication
Date de publication:
10 02 2021
10 02 2021
Historique:
accepted:
05
01
2021
entrez:
11
2
2021
pubmed:
12
2
2021
medline:
4
11
2021
Statut:
epublish
Résumé
This topical review attempts to build the concepts of PSRA as an independent entity and discuss prevalent diagnostic criteria. It utilizes a search strategy to collate all clinical features of PSRA reported from across the world and also discusses laboratory and treatment options in brief. There are several immune-mediated diseases described after acute streptococcal infections. Post-streptococcal reactive arthritis (PSRA) is a sterile, self-limiting arthritis that occur as an immune sequelae to streptococcal infection. Though PSRA resembles the arthritis of acute rheumatic fever superficially, it is a separate entity in its own right. It is different from classical reactive arthritis too. It was being recognized worldwide and more frequently in the recent past, possibly due to heightened awareness amongst clinicians. However, research on this enigmatic immune phenomenon is limited. Most acceptable hypotheses suggest molecular mimicry sensitizing the immune system towards synovial peptides such as keratin, vimentin and laminin, leading to arthritis in a genetically predisposed individual. There is still much to be learnt from this unique disease about the vagaries of the immune system.
Identifiants
pubmed: 33569668
doi: 10.1007/s11926-021-00982-3
pii: 10.1007/s11926-021-00982-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM